ST. PAUL, Minn.–(BUSINESS WIRE)– Spineology Inc., an innovator in anatomy-conserving spine surgery, is pleased to announce that John Chi, M.D., MPH, Associate Professor of Neurosurgery at Harvard Medical School and the Director of Neurosurgical Spinal...
PRINCETON, N.J., Nov. 05, 2019 (GLOBE NEWSWIRE) — Vyome Therapeutics, a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, today announced the completion of enrollment of 471...
— RRx-001 is a small molecule immunotherapy targeting CD47 – SIRPα that repolarizes tumor associated macrophages — LA JOLLA, Calif.–(BUSINESS WIRE)–EpicentRx, Inc., a clinical cancer immunotherapy company targeting both sides of the immune...
STOCKHOLM, Nov. 4, 2019 /PRNewswire/ — RhoVac AB (“RhoVac”) announces today, on 4th November 2019, that the first patient has been screened for the company’s clinical phase IIb study in prostate cancer, a study entitled RhoVac-002...
This post was originally published on this site Xtalks Life Science Webinars Now, with both the FDA and the EMA showing support for eSource, it’s time for drug sponsors and CROs to begin to change the existing industry paradigm in order to implement these advancements...
Email
Text